The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  25 (2024)
Volume  24 (2023)
Volume  23 (2022)
Volume  22 (2021)
Volume  21 (2020)
Volume  20 (2019)
Volume  19 (2018)
Volume  18 (2017)
Volume  17 (2016)
Volume  16 (2015)
Volume  15 (2014)
Volume  14 (2013)
Volume  13 (2012)
Volume  12 (2011)
Volume  11 (2010)
Volume  10 (2009)
Volume  9 (2008)
Volume  8 (2007)
Volume  7 (2006)
Volume  6 (2005)
Volume  5 (2004)
Volume  4 (2003)
Volume  3 (2002)
Volume  2 (2001)
Volume  1 (1999)
Related articles

VOLUME 8 , ISSUE 6 ( September, 2007 ) > List of Articles

RESEARCH ARTICLE

Phenobarbital-induced Gingival Hyperplasia

Ardeshir Lafzi, Ramin Mostofi Zadeh Farahani, Mohammad Ali Mohajjel Shoja

Citation Information : Lafzi A, Farahani RM, Shoja MA. Phenobarbital-induced Gingival Hyperplasia. J Contemp Dent Pract 2007; 8 (6):50-56.

DOI: 10.5005/jcdp-8-6-50

License: CC BY-NC 3.0

Published Online: 01-11-2008

Copyright Statement:  Copyright © 2007; The Author(s).


Abstract

Aim

The aim of this article is to present a case of a phenobarbital-induced gingival hyperplasia (GH), discuss possible etiological mechanisms of drug-induced GH, and to present a concise review of the literature.

Background

GH is a well-known complication associated with anticonvulsant phenytoin, antihypertensive calcium channel blockers, and immunosuppressant cyclosporine therapy. Sodium valproate and primidone has very rarely been found to cause GH.

Report

An extremely rare case of phenobarbital-induced GH in a 28-year-old male patient who had received this drug for three years is presented. The histological examination of the lesion revealed a hyperplastic epithelium, epithelial acanthosis, and elongated rete ridges as well as obviously enhanced dense collagenous fibers and proliferation of fibroblasts.

Summary

Phenobarbital-induced GH is a rare clinical entity which necessitates meticulous evaluation. However, it seems to show a benign behavior with reference to recurrence after surgical excision.

Citation

Lafzi A, Farahani RMZ, Shoja MAM. Phenobarbital-induced Gingival Hyperplasia. J Contemp Dent Pract 2007 September; (8)6:050-056.

PDF Share
  1. The subgingival microflora in phenytoininduced gingival hyperplasia. J Periodontal Res. 2003;38(5):477-81.
  2. Phenobarbitone induced gingival hyperplasia. J Neurol Neurosurg Psychiatry. 2002;73(5):601.
  3. Expression of growth factors in the gingival crevice fluid of patients with phenytoin-induced gingival enlargement. Arch Oral Biol. 2004;49(11):945-50.
  4. Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am J Pathol 1983;112:218-223.
  5. On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med 1991;20:201-209.
  6. Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody. Am J Med 1983;74:289-296.
  7. Effect of folate on phenytoin hyperplasia. J Clin Periodontol. 1987;14:350-356.
  8. An integrated model of epidermal growth factor receptor trafficking and signal transduction. Biophys J. 2003;85(2):730-43.
  9. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transforming growth factor-beta 1 expression. Dig Dis Sci. 1991;36(5):659-68.
  10. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors? Ann Diagn Pathol. 2003;7(2):73-7.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.